Todd W. Garner - 09 Dec 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Executive Vice President & CFO
Signature: Sarah M. Oliker for Todd W. Garner by Power of Attorney
Issuer symbol: CNMD
Transactions as of: 09 Dec 2022
Transactions value $: $-174,150
Form type: 4
Filing time: 12 Dec 2022, 16:08:19 UTC
Previous filing: 07 Jul 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$227,745	+4,500	+450000%	$50.61	4,501	09 Dec 2022	Direct
transaction	CNMD	Common Stock	Sale	$-401,895	-4,500	-100%	$89.31	1	09 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Options To Purchase Common Stock	Options Exercise	$0	-4,500	-11.4%	$0.000000	35,100	09 Dec 2022	Common Stock	4,500	$50.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan.
F2	Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.

Content

The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan.

Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.